Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of COP 548.89 trillion. The enterprise value is 746.94 trillion.

Market Cap	548.89T
Enterprise Value	746.94T

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.75%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 18.73 and the forward PE ratio is 8.89.

PE Ratio	18.73
Forward PE	8.89
PS Ratio	2.33
PB Ratio	1.68
P/TBV Ratio	n/a
P/FCF Ratio	16.04
P/OCF Ratio	12.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.69, with an EV/FCF ratio of 21.83.

EV / Earnings	25.49
EV / Sales	3.28
EV / EBITDA	7.69
EV / EBIT	10.70
EV / FCF	21.83

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.15B
Profits Per Employee	390.69M
Employee Count	75,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-1,003.01B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.19%
50-Day Moving Average	99,112.80
200-Day Moving Average	97,837.00
Relative Strength Index (RSI)	44.07
Average Volume (20 Days)	2,242

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.24

Income Statement

In the last 12 months, Pfizer had revenue of COP 235.97 trillion and earned 29.30 trillion in profits. Earnings per share was 5,144.65.

Revenue	235.97T
Gross Profit	178.88T
Operating Income	72.26T
Pretax Income	28.36T
Net Income	29.30T
EBITDA	96.97T
EBIT	72.26T
Earnings Per Share (EPS)	5,144.65

Balance Sheet

The company has 51.27 trillion in cash and 255.08 trillion in debt, giving a net cash position of -203,810.11 billion.

Cash & Cash Equivalents	51.27T
Total Debt	255.08T
Net Cash	-203,810.11B
Net Cash Per Share	n/a
Equity (Book Value)	327.20T
Book Value Per Share	57,347.00
Working Capital	22.30T

Cash Flow

In the last 12 months, operating cash flow was 44.13 trillion and capital expenditures -9,913.17 billion, giving a free cash flow of 34.22 trillion.

Operating Cash Flow	44.13T
Capital Expenditures	-9,913.17B
Depreciation & Amortization	23.81T
Net Borrowing	-268.88B
Free Cash Flow	34.22T
FCF Per Share	n/a

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 6,770.35, which amounts to a dividend yield of 7.06%.

Dividend Per Share	6,770.35
Dividend Yield	7.06%
Dividend Growth (YoY)	-3.07%
Years of Dividend Growth	1
Payout Ratio	131.60%
Buyback Yield	-0.23%
Shareholder Yield	6.74%
Earnings Yield	5.34%
FCF Yield	6.23%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6